Unknown

Dataset Information

0

A case report: symptomatic pericarditis post-COVID-19 vaccination


ABSTRACT: Abstract

Background 

The Coronavirus disease 2019 (COVID-19) pandemic has led to the rapid development of COVID-19 vaccine. The Centers for Disease Control and Prevention (CDC) has recently reported increase in myopericarditis incidence post-COVID-19 vaccination. Post-vaccination myopericarditis as side effect has been reported, however, is infrequent. We described a case of pericarditis post-first dose of Pfizer-BioNTech vaccine.

Case summary

A patient presented with typical symptoms of pericarditis and related electrocardiogram and echocardiogram changes, 7 days post receiving the first dose of COVID-19 vaccine. No other causes were identified from series of investigations. Patient had good symptomatic relief with non-steroidal anti-inflammatory medication.

Discussion

The incidence of pericarditis post-vaccination is rare, with limited reporting in previous literatures. No causal relationship has yet to be established due to small number of cases. The benefits of COVID-19 vaccination currently outweigh the side effect profile and are recommended as the first-line approach to control the current pandemic.

SUBMITTER: Ashaari S 

PROVIDER: S-EPMC8522432 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7898573 | biostudies-literature
| S-EPMC8724022 | biostudies-literature
| S-EPMC8340007 | biostudies-literature
| S-EPMC9350430 | biostudies-literature
| S-EPMC8250535 | biostudies-literature
| S-EPMC9276870 | biostudies-literature
| S-EPMC8608684 | biostudies-literature
| S-EPMC9239840 | biostudies-literature
2023-02-22 | GSE171052 | GEO
| S-EPMC8452461 | biostudies-literature